Renal Cancer - Results from #2320

Apalutamide for metastatic, castration-sensitive prostate cancer in the Japanese population: A subgroup analysis of the randomized, double-blind, placebo-controlled phase 3 TITAN study. December 11, 2020

Clinical and Pathological Characteristics of Metastatic Renal Cell Carcinoma Patients Needing a Second-Line Therapy: A Systematic Review. December 11, 2020

Comparison of Radiological Tumor Response Based on iRECIST and RECIST 1.1 in Metastatic Clear-Cell Renal Cell Carcinoma Patients Treated with Programmed Cell Death-1 Inhibitor Therapy. December 10, 2020

A Randomized Phase II Study of AGS-16C3F Versus Axitinib in Previously Treated Patients with Metastatic Renal Cell Carcinoma. December 10, 2020

Stereotactic Radiotherapy for the Treatment of Patients With Oligo-progressive Metastatic Renal Cell Carcinoma Receiving Vascular Endothelial Growth Factor Receptor Tyrosine Kinase Inhibitor: Data From the Real World. December 10, 2020

Survival nomogram for patients with bone metastatic renal cell carcinoma: A population-based study. December 9, 2020

The Association Between Race and 5-year Survival in Patients with Clear Cell Renal Cell Carcinoma: A Cohort Study. December 9, 2020

Pembrolizumab plus axitinib versus sunitinib monotherapy as first-line treatment of advanced renal cell carcinoma (KEYNOTE-426): extended follow-up from a randomised, open-label, phase 3 trial. December 9, 2020

Determining generalizability of the Canadian Kidney Cancer information system (CKCis) to the entire Canadian kidney cancer population. December 8, 2020

Modified Glasgow Prognostic Score as a Predictor of Prognosis in Metastatic Renal Cell Carcinoma Treated With Nivolumab. December 8, 2020

The critical impact of tumor size in predicting cancer special survival for T3aM0M0 renal cell carcinoma: A proposal of an alternative T3aN0M0 stage. December 8, 2020

The HPV and p63 status in penile cancer are linked with the infiltration and therapeutic availability of neutrophils. December 7, 2020

The Impact of Renal Impairment on Survival Outcomes in Patients With Metastatic Renal Cell Carcinoma Treated With Tyrosine Kinase Inhibitors. December 7, 2020

Long-term functional and oncological outcomes of robot-assisted partial nephrectomy for cystic renal tumors: a single-center retrospective study. December 7, 2020

Construction of a Novel Multigene Panel Potently Predicting Poor Prognosis in Patients with Clear Cell Renal Cell Carcinoma. December 7, 2020

Distinguishing Benign Renal Tumors with an Oncocytic Gene Expression (ONEX) Classifier. December 5, 2020

Artificial Neural Networks as a Way to Predict Future Kidney Cancer Incidence in the United States. December 4, 2020

Development and Validation of an Individualized Immune-Related Gene Pairs Prognostic Signature in Papillary Renal Cell Carcinoma. December 4, 2020

To Stage or Not to Stage: Determining the True Clinical Significance of the Biopsy Tract Through Perinephric Fat in Assessing Renal Cell Carcinoma. December 4, 2020

Arterial Spin Labeled Perfusion MRI for the Evaluation of Response to Tyrosine Kinase Inhibition Therapy in Metastatic Renal Cell Carcinoma. December 3, 2020

Page 117 of 456